LEE WILLIS C
SEC insider (Form 3/4/5 filer). CIK 0001517775. CEO at Emmaus Life Sciences, Inc. (EMMA). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in TORRANCE, CA.
Companies LEE WILLIS C has filed insider reports for
- Emmaus Life Sciences, Inc. (EMMA): Director, Officer, CEO
LEE WILLIS C
CIK: 0001517775
Transaction Breakdown
Open Market Buys (P)6 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EMMA
Emmaus Life Sciences, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 31, 2026EMMA
Emmaus Life Sciences, Inc.
PurchaseIndirect100K shares at avg. $0.05$5K - Aug 28, 2026EMMA
Emmaus Life Sciences, Inc.
PurchaseIndirect94.8K shares at avg. $0.06$6K - Aug 27, 2026EMMA
Emmaus Life Sciences, Inc.
PurchaseIndirect50K shares at avg. $0.05$3K - Aug 25, 2026EMMA
Emmaus Life Sciences, Inc.
PurchaseIndirect46K shares at avg. $0.04$2K - Aug 29, 2025EMMA
Emmaus Life Sciences, Inc.
PurchaseIndirect170K shares at avg. $0.01$2K - May 30, 2025EMMA
Emmaus Life Sciences, Inc.
PurchaseIndirect70K shares at avg. $0.02$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 | EMMA Emmaus Life Sciences, Inc. | Purchase | 100,000 | $0.05 | $5,000 | Indirect |
| Aug 28, 2026 | EMMA Emmaus Life Sciences, Inc. | Purchase | 94,767 | $0.06 | $5,686 | Indirect |
| Aug 27, 2026 | EMMA Emmaus Life Sciences, Inc. | Purchase | 50,000 | $0.05 | $2,500 | Indirect |
| Aug 25, 2026 | EMMA Emmaus Life Sciences, Inc. | Purchase | 46,000 | $0.04 | $1,840 | Indirect |
| Aug 29, 2025 | EMMA Emmaus Life Sciences, Inc. | Purchase | 170,000 | $0.01 | $1,700 | Indirect |
| May 30, 2025 | EMMA Emmaus Life Sciences, Inc. | Purchase | 70,000 | $0.02 | $1,400 | Indirect |
1-6 of 6 transactions